BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8991803)

  • 1. Prejunctional actions of K+ channel blockers in rat vas deferens.
    Docherty JR; Brady G
    Eur J Pharmacol; 1995 Dec; 287(3):287-93. PubMed ID: 8991803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of adrenergic responses of human vas deferens by K+ channel inhibitors.
    Medina P; Segarra G; Mauricio MD; Vila JM; Chuan P; Lluch S
    Urology; 2010 Dec; 76(6):1518.e7-12. PubMed ID: 20932556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.
    Kanwal S; Trachte GJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):117-23. PubMed ID: 7507992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired pulse analysis of ATP and noradrenaline release from sympathetic nerves of rat tail artery and mouse vas deferens: effects of K+ channel blockers.
    Msghina M; Gonon F; Stjärne L
    Br J Pharmacol; 1998 Dec; 125(8):1669-76. PubMed ID: 9886758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further examination of the inhibitory actions of alpha 1-adrenoceptor agonists in rat vas deferens.
    Warnock P; Hyland L; Docherty JR
    Eur J Pharmacol; 1985 Jul; 113(2):239-45. PubMed ID: 2412843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1996 Jan; 117(1):224-30. PubMed ID: 8825367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on the role of P2X-purinoceptor activation in human vas deferens contractility.
    Amobi NI; Guillebaud J; Smith IC
    Exp Physiol; 2012 May; 97(5):583-602. PubMed ID: 22227201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of alpha-adrenoceptor responsiveness in the vas deferens of spontaneously hypertensive rats.
    Docherty JR; Warnock P
    Br J Pharmacol; 1985 Oct; 86(2):327-33. PubMed ID: 2413944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
    Rajamani K; Leong S; Lavelle A; Docherty JR
    Eur J Pharmacol; 2001 Jul; 423(2-3):223-8. PubMed ID: 11448488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique effect of tetrapentylammonium ions on sympathetic transmission in rat vas deferens.
    Huang Y; Lau CW
    J Auton Pharmacol; 1998 Jun; 18(3):189-94. PubMed ID: 9754639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity of butylidenephthalide on non-adrenergic prejunctional voltage-dependent Ca(2+) channels in prostatic portion of rat vas deferens.
    Shih CH; Chen CM; Ko WC
    Eur J Pharmacol; 2016 Sep; 786():47-52. PubMed ID: 27238973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of intracellular Ca2+ stores in inhibitory effects of NO donor SIN-1 and cGMP.
    Franck H; Storr M; Puschmann A; Schusdziarra V; Allescher HD
    Am J Physiol; 1998 Jul; 275(1):G159-68. PubMed ID: 9655696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BaCl2- and 4-aminopyridine-evoked phasic contractions in the rat vas deferens.
    Huang Y
    Br J Pharmacol; 1995 Jul; 115(5):845-51. PubMed ID: 8548186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K+ and Ca2+ channel blockers may enhance or depress sympathetic transmitter release via a Ca(2+)-dependent mechanism "upstream" of the release site.
    Stjärne L; Stjärne E; Msghina M; Bao JX
    Neuroscience; 1991; 44(3):673-92. PubMed ID: 1661385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic basis of the action potential of guinea pig gallbladder smooth muscle cells.
    Zhang L; Bonev AD; Nelson MT; Mawe GM
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1552-61. PubMed ID: 7506489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of the potassium currents in rat aortic smooth muscle cells during postnatal development.
    Gomez JP; Ghisdal P; Morel N
    Pflugers Arch; 2000 Dec; 441(2-3):388-97. PubMed ID: 11211127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the actions of the calcium entry facilitator Bay K 8644 on the rat vas deferens.
    Hyland L; Warnock P; Docherty JR
    Eur J Pharmacol; 1984 Sep; 104(3-4):363-7. PubMed ID: 6209150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.